Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from PainReform ( (PRFX) ).
On February 18, 2026, PRF Technologies announced that its DeepSolar unit signed its first commercial technical due diligence engagement with a subsidiary of EDF Group’s Israeli renewable-energy arm, covering an operational utility-scale solar plant in Israel. The deal marks a new revenue-generating phase for DeepSolar’s Smart TDD analytics service, which ingests historical and real-time plant data to provide structured, independent reviews of asset condition and performance.
DeepSolar’s Smart TDD is designed as a repeatable, data-driven solution that supports commissioning checks, warranty-expiry assessments, underperformance diagnostics, and asset-acquisition evaluations across a solar plant’s lifecycle. By formalizing this collaboration with a major global renewable-energy player, PRF strengthens DeepSolar’s commercial validation and positions itself more firmly within the utility-scale solar analytics market, signaling potential for expanded use of its AI-based due diligence tools among large solar asset operators.
The most recent analyst rating on (PRFX) stock is a Sell with a $0.64 price target. To see the full list of analyst forecasts on PainReform stock, see the PRFX Stock Forecast page.
Spark’s Take on PRFX Stock
According to Spark, TipRanks’ AI Analyst, PRFX is a Neutral.
The score is weighed down primarily by weak financial performance (minimal revenue, widening losses, and rising cash burn alongside shrinking equity). Technicals also remain bearish with the stock trading below key moving averages, while valuation cannot be meaningfully assessed due to missing P/E and dividend yield data.
To see Spark’s full report on PRFX stock, click here.
More about PainReform
PRF Technologies Ltd., formerly PainReform, operates a dual business model spanning pharmaceuticals and energy technology. The Nasdaq-listed company is reformulating established therapeutics via a proprietary extended-release drug-delivery system aimed at prolonged post-surgical pain relief with reduced opioid use, while its DeepSolar platform develops AI-driven tools to monitor, forecast, and optimize energy consumption in solar-integrated environments. DeepSolar also focuses on digital asset management for utility-scale solar plants, using advanced algorithms to turn operational data into actionable performance and profitability insights.
Average Trading Volume: 532,076
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.32M
Learn more about PRFX stock on TipRanks’ Stock Analysis page.